Table 1

Characteristics of inclusion studies

First author (publication year)Study designCountrySample sizeMean age/rangeYearOutcome
(Cantor et al 2018)13Cross-sectional studyColombia1272>502014–2015POAG
(Deb et al 2014)24Cross-sectional studyIndia208HT No: 55.1±7.1 HTN: 55.5±6.22010–2012POAG
(Hulsman 2007)25Cohort studyNetherlands5317OAG No: 68.8±8.8 OAG: 73.3±7.31990–1999OAG
(Ishikawa et al 2011)23Cross-sectional studyJapan710POAG No: 53.4±9.9
POAG: 58.8±10.6
2007POAG
(Kawasaki et al 2013)21Cohort studyAustralia2417OAG No: 64.1±8.5
OAG: 68.2±8.2
2003OAG
(Kim et al 2012)26Cross-sectional studySouth Korea1464POAG No: 63.5±11.6
POAG: 68.4±10.1
2008POAG
(Kim KE et al 2016)27Cross-sectional studyKorean13 83155.1±0.22008–2011POAG
(Kim H-A et al 2016)14Cross-sectional studyKorean8816≥402010–2012POAG
(Kyari et al 2016)28Case–control studyNigeria13 200OAG No: 55.4±12.1
OAG: 66.2±12.3
2005–2007OAG
(Memarzadeh et al 2010)11Cross-sectional studyAmerican6130OAG No: 54.4±10.6
OAG: 65.4±11.7
2008OAG
(Onakoya et al 2009)15Case–control studyNigeria200POAG No: 54.7±9.65
POAG: 56.7±12.95
2004POAG
(Shakya-Vaidya et al 2013)16Case–control studyNepal683POAG No: 58.54±14.6
POAG: 58.90±14.72
2010–2011POAG
(Suzuki et al 2006)29Cross-sectional studyJapan2874POAG No: 57.8±11.6
POAG: 63.8±12.0,
2000–2001POAG
(Tham et al 2018)30Cross-sectional studySingapore9877POAG No: 63.4±10.8
POAG: 58.2±10.1
2017POAG
(Topouzis et al 2013)31Cross-sectional studyNorthern Greece1991POAG No: 70.35±5.5
POAG: 72.7±6.1
1999POAG
(Wang et al 2009)17Cross-sectional studyChina322260.4±10.02001–2006POAG
  • HTN, hypertension; OAG, open-angle glaucoma; POAG, primary open-angle glaucoma.